Clinical Trials Browser

Withdrawn × Interventional × Endoscopy × Clear all

NCT05660421 2024-10-31

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Phase 2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms

NCT01209013 2012-05-08

Oedisse

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus